Investment Team
-
Current Companies
-
-
Prior Companies
-
Matthew Rieke, M.D.
-
Founding Principal of Quaker BioVentures and promoted to Partner in 2005
-
Previously: Principal at PA Early Stage, a venture capital fund investing in early stage life science and IT companies. Created start-up companies based on Penn faculty inventions at the University of Pennsylvania Center for Technology Transfer. Management consultant with CSC Healthcare, focusing on disease management protocols. Researched novel therapeutics and bone marrow transplantation at Cedars-Sinai Medical Center.
-
Board Responsibilities: Neotropix, Nitric BioTherapeutics, Tarsa Therapeutics, TearScience and TransEnterix
-
Board Observer Responsibilities: Biolex and Neuronetics
-
Prior Board Participation: BioRexis (acquired by Pfizer)
-
Other: Advisor for AdvaMed. Member of the BIOVenture Forum East Advisory Board, the Biotech and Life Sciences Advisory Committee for Ben Franklin Technology Partners of SE PA, and the Life Sciences Greenhouse of Central PA.
-
Education: B.A. from Colgate University, Doctor of Medicine from the University of Pennsylvania School of Medicine, M.B.A. from the Wharton School of the University of Pennsylvania. Maintains active medical license.
